All lobbying filings

BUCHANAN INGERSOLL & ROONEY PC

BUCHANAN INGERSOLL & ROONEY PC filed a Q4 report for VIDRINE PHARMACEUTICAL GROUP, LLC D/B/A BOUDREAUXS NEW DRUG STORE on January 20, 2026, reporting $40,000 in lobbying income.

Lobbying for VIDRINE PHARMACEUTICAL GROUP, LLC D/B/A BOUDREAUXS NEW DRUG STORE · Pharmaceutical company

All filings by BUCHANAN INGERSOLL & ROONEY PC · Everything VIDRINE PHARMACEUTICAL GROUP, LLC D/B/A BOUDREAUXS NEW DRUG STORE has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Louisiana

Official filing document

Lobbyists on this filing 1

AMANDA LINCOLN

Previously held: Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Issues related to compounding

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.